Search research articles
Contact Us
Filters
Showing results (1-10 of 102) with videos related to
Page
of 11
Sort By:
Acta Oncologica (Stockholm, Sweden)
|
September 17, 2005
Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?
Hans von der Maase
Ugeskrift for Laeger
|
April 6, 2006
[Dendritic cell vaccination--a new therapeutic alternative for cancer patients?]
Hans von der Maase
Expert Review of Anticancer Therapy
|
February 25, 2003
Gemcitabine in transitional cell carcinoma of the urothelium
Hans von der Maase
Oncology (Williston Park, N.Y.)
|
January 20, 2005
Pemetrexed in transitional cell carcinoma of the urothelium
Hans von der Maase
Ugeskrift for Laeger
|
June 27, 2002
[Oncologic treatment]
Hans von der Maase
European Urology
|
April 17, 2007
Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen
Hans von der Maase
Seminars in Oncology
|
March 15, 2002
Current and future perspectives in advanced bladder cancer: is there a new standard?
Hans von der Maase
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma
Frede Donskov, Hans von der Maase
Ugeskrift for Laeger
|
December 10, 2002
[Renal cancer--a new clearing report]
Hans Colstrup, Hans von der Maase
Ugeskrift for Laeger
|
June 27, 2002
[Urinary bladder cancer]
Hans von der Maase, Kenneth Steven
Page
of 11
Search research articles
Search
Showing results (1-10 of 102) with videos related to
Sort By:
Page
of 11
Acta Oncologica (Stockholm, Sweden)
|
September 17, 2005
Is a contralateral testicular biopsy in patients with unilateral germ cell testicular cancer indicated as a routine procedure?
Hans von der Maase
Ugeskrift for Laeger
|
April 6, 2006
[Dendritic cell vaccination--a new therapeutic alternative for cancer patients?]
Hans von der Maase
Expert Review of Anticancer Therapy
|
February 25, 2003
Gemcitabine in transitional cell carcinoma of the urothelium
Hans von der Maase
Oncology (Williston Park, N.Y.)
|
January 20, 2005
Pemetrexed in transitional cell carcinoma of the urothelium
Hans von der Maase
Ugeskrift for Laeger
|
June 27, 2002
[Oncologic treatment]
Hans von der Maase
European Urology
|
April 17, 2007
Editorial comment on: Weekly paclitaxel and carboplatin against advanced transitional cell cancer after failure of a platinum-based regimen
Hans von der Maase
Seminars in Oncology
|
March 15, 2002
Current and future perspectives in advanced bladder cancer: is there a new standard?
Hans von der Maase
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2006
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma
Frede Donskov, Hans von der Maase
Ugeskrift for Laeger
|
December 10, 2002
[Renal cancer--a new clearing report]
Hans Colstrup, Hans von der Maase
Ugeskrift for Laeger
|
June 27, 2002
[Urinary bladder cancer]
Hans von der Maase, Kenneth Steven
Page
of 11